Christofori, Gerhard

Up a level
Export as [feed] RSS
Group by: Item Type | No Grouping
Number of items: 8.

Journal Article

Lüönd, Fabiana; Bill, Ruben; Vettiger, Andrea; Oller, Heide; Pelczar, Pawel; Christofori, Gerhard (2019). A Transgenic MMTV-Flippase Mouse Line for Molecular Engineering in Mammary Gland and Breast Cancer Mouse Models. Journal of mammary gland biology and neoplasia, 24(1), pp. 39-45. Springer 10.1007/s10911-018-9412-4

Tiede, Stefanie; Meyer-Schaller, Nathalie; Kalathur, Ravi Kiran Reddy; Ivanek, Robert; Fagiani, Ernesta; Schmassmann, Philip; Stillhard, Patrick; Häfliger, Simon; Kraut, Norbert; Schweifer, Norbert; Waizenegger, Irene C; Bill, Ruben; Christofori, Gerhard (2018). The FAK inhibitor BI 853520 exerts anti-tumor effects in breast cancer. Oncogenesis, 7(9), p. 73. Springer Nature 10.1038/s41389-018-0083-1

Wicki, Andreas; Wild, Damian; Prêtre, Vincent; Mansi, Rosalba; Orleth, Annette; Reubi, Jean-Claude; Rochlitz, Christoph; Mamot, Christoph; Mäcke, Helmut R; Christofori, Gerhard (2014). Synergism of peptide receptor-targeted Auger electron radiation therapy with anti-angiogenic compounds in a mouse model of neuroendocrine tumors. EJNMMI research, 4(1), p. 9. Springer 10.1186/2191-219X-4-9

Saupe, Falk; Schwenzer, Anja; Jia, Yundan; Gasser, Isabelle; Spenlé, Caroline; Langlois, Benoit; Kammerer, Martial; Lefebvre, Olivier; Hlushchuk, Ruslan; Rupp, Tristan; Marko, Marija; van der Heyden, Michael; Cremel, Gérard; Arnold, Christiane; Klein, Annick; Simon-Assmann, Patricia; Djonov, Valentin; Neuville-Méchine, Agnès; Esposito, Irene; Slotta-Huspenina, Julia; ... (2013). Tenascin-C downregulates wnt inhibitor dickkopf-1, promoting tumorigenesis in a neuroendocrine tumor model. Cell reports, 5(2), pp. 482-492. Cell Press 10.1016/j.celrep.2013.09.014

Wicki, Andreas; Wild, Damian; Storch, Daniel; Seemayer, Christian; Gotthardt, Martin; Behe, Martin; Kneifel, Stefan; Mihatsch, Michael J; Reubi, Jean-Claude; Mäcke, Helmut R; Christofori, Gerhard (2007). [Lys40(Ahx-DTPA-111In)NH2]-Exendin-4 is a highly efficient radiotherapeutic for glucagon-like peptide-1 receptor-targeted therapy for insulinoma. Clinical cancer research, 13(12), pp. 3696-705. Philadelphia, Pa.: American Association for Cancer Research 10.1158/1078-0432.CCR-06-2965

Kopfstein, Lucie; Veikkola, Tanja; Djonov, Valentin G; Baeriswyl, Vanessa; Schomber, Tibor; Strittmatter, Karin; Stacker, Steven A; Achen, Marc G; Alitalo, Kari; Christofori, Gerhard (2007). Distinct roles of vascular endothelial growth factor-D in lymphangiogenesis and metastasis. American journal of pathology, 170(4), pp. 1348-61. New York, N.Y.: Elsevier 10.2353/ajpath.2007.060835

Schomber, Tibor; Kopfstein, Lucie; Djonov, Valentin; Albrecht, Imke; Baeriswyl, Vanessa; Strittmatter, Karin; Christofori, Gerhard (2007). Placental growth factor-1 attenuates vascular endothelial growth factor-A-dependent tumor angiogenesis during beta cell carcinogenesis. Cancer research, 67(22), pp. 10840-8. Birmingham, Ala.: American Association for Cancer Research AACR 10.1158/0008-5472CAN-07-1034

Wild, Damian; Béhé, Martin; Wicki, Andreas; Storch, Daniel; Waser, Beatrice; Gotthardt, Martin; Keil, Boris; Christofori, Gerhard; Reubi, Jean Claude; Mäcke, Helmut R (2006). [Lys40(Ahx-DTPA-111In)NH2]exendin-4, a very promising ligand for glucagon-like peptide-1 (GLP-1) receptor targeting. Journal of nuclear medicine, 47(12), pp. 2025-33. New York, N.Y.: Society of Nuclear Medicine

This list was generated on Fri Apr 19 00:55:05 2024 CEST.
Provide Feedback